These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16949225)

  • 1. Design of a transdermal delivery system for aspirin as an antithrombotic drug.
    Ammar HO; Ghorab M; El-Nahhas SA; Kamel R
    Int J Pharm; 2006 Dec; 327(1-2):81-8. PubMed ID: 16949225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A transdermal delivery system for glipizide.
    Ammar HO; Salama HA; Ghorab M; El-Nahhas SA; Elmotasem H
    Curr Drug Deliv; 2006 Jul; 3(3):333-41. PubMed ID: 16848735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and in vitro/in vivo evaluation of levodopa transdermal delivery systems.
    Lee KE; Choi YJ; Oh BR; Chun IK; Gwak HS
    Int J Pharm; 2013 Nov; 456(2):432-6. PubMed ID: 24008082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
    Yang Z; Teng Y; Wang H; Hou H
    Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro permeation of carvedilol through porcine skin: effect of vehicles and penetration enhancers.
    Gannu R; Vishnu YV; Kishan V; Rao YM
    PDA J Pharm Sci Technol; 2008; 62(4):256-63. PubMed ID: 19174954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced transdermal delivery of loratadine from the EVA matrix.
    Cho CW; Choi JS; Kim SJ; Shin SC
    Drug Deliv; 2009 May; 16(4):230-5. PubMed ID: 19514983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of a Dissolving Microneedle Platform for Transdermal Delivery of a Fixed-Dose Combination of Cardiovascular Drugs.
    Quinn HL; Bonham L; Hughes CM; Donnelly RF
    J Pharm Sci; 2015 Oct; 104(10):3490-500. PubMed ID: 26149914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced stability and permeation potential of nanoemulsion containing sefsol-218 oil for topical delivery of amphotericin B.
    Hussain A; Samad A; Singh SK; Ahsan MN; Faruk A; Ahmed FJ
    Drug Dev Ind Pharm; 2015 May; 41(5):780-90. PubMed ID: 24654936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin.
    Nair A; Vyas H; Shah J; Kumar A
    Drug Deliv; 2011 Jan; 18(1):19-25. PubMed ID: 20726811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies.
    Panchagnula R; Bokalial R; Sharma P; Khandavilli S
    Int J Pharm; 2005 Apr; 293(1-2):213-23. PubMed ID: 15778059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems.
    Babu RJ; Pandit JK
    Int J Pharm; 2005 Jan; 288(2):325-34. PubMed ID: 15620873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fatty acids on the transdermal delivery of donepezil: in vitro and in vivo evaluation.
    Choi J; Choi MK; Chong S; Chung SJ; Shim CK; Kim DD
    Int J Pharm; 2012 Jan; 422(1-2):83-90. PubMed ID: 22037444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microemulsions as transdermal drug delivery vehicles.
    Kogan A; Garti N
    Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and development of insulin emulgel formulation for transdermal drug delivery and its evaluation.
    Akram M; Naqvi SB; Khan A
    Pak J Pharm Sci; 2013 Mar; 26(2):323-32. PubMed ID: 23455203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of formulation excipients on the penetration and lateral diffusion of ibuprofen on and within the stratum corneum following topical application to humans.
    Gee CM; Watkinson AC; Nicolazzo JA; Finnin BC
    J Pharm Sci; 2014 Mar; 103(3):909-19. PubMed ID: 24421242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limonene GP1/PG organogel as a vehicle in transdermal delivery of haloperidol.
    Lim PF; Liu XY; Kang L; Ho PC; Chan YW; Chan SY
    Int J Pharm; 2006 Mar; 311(1-2):157-64. PubMed ID: 16451823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal absorption of natural progesterone from alcoholic gel formulations with hydrophilic surfactant.
    Matsui R; Ueda O; Uchida S; Namiki N
    Drug Dev Ind Pharm; 2015 Jun; 41(6):1026-9. PubMed ID: 24980912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic characteristics of formulated alendronate transdermal delivery systems in rats and humans.
    Choi A; Gang H; Whang J; Gwak H
    Drug Deliv; 2010 May; 17(4):249-54. PubMed ID: 20214414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.